Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 6
Submit an article Journal homepage
330
Views
18
CrossRef citations to date
0
Altmetric
Original Research

The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease

Anja VogtKlinikum der Universität München, Medizinische Klinik und Poliklinik IV, Ziemssenstrasse 1, Munich, 80336, Germany+49 89 51603575; +49 89 51604562; [email protected]
&
Klaus G ParhoferKlinikum der Universität München, Medizinische Klinik II, München, Germany
Pages 691-697 | Published online: 11 Mar 2013

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Anja Vogt. (2015) The genetics of familial hypercholesterolemia and emerging therapies. The Application of Clinical Genetics 8, pages 27-36.
Read now
Michael M Page & Gerald F Watts. (2015) Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention. Expert Opinion on Emerging Drugs 20:2, pages 299-312.
Read now
Arrigo FG Cicero, Elisa Tartagni & Sibel Ertek. (2014) Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data. Expert Opinion on Drug Safety 13:8, pages 1023-1030.
Read now

Articles from other publishers (15)

David Rhainds, Mathieu R. Brodeur & Jean-Claude Tardif. (2021) Lipoprotein (a): When to Measure and How to Treat?. Current Atherosclerosis Reports 23:9.
Crossref
Behrooz Astaneh, Nima Makhdami, Vala Astaneh & Gordon Guyatt. (2021) The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials. Journal of Cardiovascular Development and Disease 8:7, pages 82.
Crossref
David T W Lui, Alan C H Lee & Kathryn C B Tan. (2021) Management of Familial Hypercholesterolemia: Current Status and Future Perspectives. Journal of the Endocrine Society 5:1.
Crossref
V. К. Zafiraki, Е. D. Kosmacheva, I. N. Zakharova, V. A. Korneva & A. V. Susekov. (2018) Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment. Medical Council:17, pages 253-259.
Crossref
Anja Vogt. (2017) Lipoprotein(a)-apheresis in the light of new drug developments. Atherosclerosis Supplements 30, pages 38-43.
Crossref
Anja Vogt. (2017) Hyperlipoproteinaemia(a) – apheresis and emerging therapies. Clinical Research in Cardiology Supplements 12:S1, pages 12-17.
Crossref
Susanne Voelter-Mahlknecht. (2016) Epigenetic associations in relation to cardiovascular prevention and therapeutics. Clinical Epigenetics 8:1.
Crossref
Denuja Karunakaran & Katey J. Rayner. (2016) Macrophage miRNAs in atherosclerosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861:12, pages 2087-2093.
Crossref
Jing Pang, Dick C. Chan & Gerald F. Watts. 2015. Combination Therapy In Dyslipidemia. Combination Therapy In Dyslipidemia 73 86 .
Gerald Klose, Ulrich Laufs, Winfried März & Eberhard Windler. (2014) Familial Hypercholesterolemia. Deutsches Ärzteblatt international.
Crossref
Gerald F. Watts, Samuel Gidding, Anthony S. Wierzbicki, Peter P. Toth, Rodrigo Alonso, W. Virgil Brown, Eric Bruckert, Joep Defesche, Khoo Kah Lin, Michael Livingston, Pedro Mata, Klaus G. Parhofer, Frederick J. Raal, Raul D. Santos, Eric J.G. Sijbrands, William G. Simpson, David R. Sullivan, Andrey V. Susekov, Brian Tomlinson, Albert Wiegman, Shizuya Yamashita & John J.P. Kastelein. (2014) Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. Journal of Clinical Lipidology 8:2, pages 148-172.
Crossref
Gerald F. Watts, Samuel Gidding, Anthony S. Wierzbicki, Peter P. Toth, Rodrigo Alonso, W. Virgil Brown, Eric Bruckert, Joep Defesche, Khoo Kah Lin, Michael Livingston, Pedro Mata, Klaus G. Parhofer, Frederick J. Raal, Raul D. Santos, Eric J.G. Sijbrands, William G. Simpson, David R. Sullivan, Andrey V. Susekov, Brian Tomlinson, Albert Wiegman, Shizuya Yamashita & John J.P. Kastelein. (2014) Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. International Journal of Cardiology 171:3, pages 309-325.
Crossref
Masataka Kusunoki, Kazuhiko Tsutsumi, Daisuke Sato, Tetsuro Miyata & Takao Nakamura. (2014) Effects of Fasting on Plasma Lipoprotein(a) in Cynomolgus Monkeys: Preliminary Experiments Results. Open Journal of Animal Sciences 04:05, pages 222-227.
Crossref
Salman J. Bandeali, Jad Daye & Salim S. Virani. (2013) Novel Therapies for Treating Familial Hypercholesterolemia. Current Atherosclerosis Reports 16:1.
Crossref
Anja Vogt. (2013) Schwere, asymptomatische Hypercholesterinämie im jungen Lebensalter. CardioVasc 13:6, pages 39-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.